OpenVSafe by OpenVAERS
Search V-safe

YJ7-33841-01089

2 vaccinations 3 coded responses 19 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
774 / TX
Registered
2020-12-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Joint pains, Nausea
    Adult check-in
  8. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  9. 2021-01-03
    Survey response — day 14, dose 1
    MedDRA: Ageusia, Anosmia, Fatigue, Nasal congestion — Feeling: Good · Be unable to work
    Free text: Nasal congestion, loss of smell/taste, fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-03
    Report sent to call center — day 14, dose 1
    Be unable to work
    1 call case(s)
  11. 2021-01-08
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-08
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-01-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches
    Adult check-in
  14. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-17
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-01-29
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-07-09
    Survey response — 6 months, dose 2
    MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Pregnancy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-07-09
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-07-27
  25. 2022-01-10
    Survey response — 12 months, dose 2
    MedDRA: Gestational hypertension, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Pregnancy induced hypertension Preeclampsia
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-01-10
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  27. 2022-01-11

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-08Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-01-03 priority 2/3
2021-07-09 Unsuccessful
2022-01-10 Unsuccessful

Free text

Release 1 — day 14, dose 1

2021-01-03

Symptoms: Nasal congestion, loss of smell/taste, fatigue

Release 9 — 6 months, dose 2

2021-07-09

Symptoms: Pregnancy

Release 10 — 12 months, dose 2

2022-01-10

Symptoms: Pregnancy induced hypertension Preeclampsia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia ✓ ✓ ✓
SDAnosmia ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDGestational hypertension · · ✓
SDNasal congestion ✓ ✓ ✓
SDPre-eclampsia · · ✓
SDPregnancy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release